Sales Tax Tax Credits and Other Receivables |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov. 30, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||
| Sales Tax Tax Credits and Other Receivables | ||||||||||||||||||||||||||||||||||||||||||||||
| 3. Sales Tax, Tax Credits and Other Receivables | 3. Sales Tax, Tax Credits and Other Receivables
Sales tax, research and development tax credits and other receivables as at November 30, 2021 and February 28, 2021 were as follows:
In the nine-month period ended November 30, 2021, the Company received 327,429 (2021 – nil) reimbursable research and development tax credits in cash. |
|||||||||||||||||||||||||||||||||||||||||||||